Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma
Background Renal medullary carcinoma (RMC) is a rare kidney tumor that occurs in adolescent and young adults, typically in association with sickle cell trait. RMC exhibits rapid disease progression, frequent metastases at diagnosis, and dismal clinical outcomes. Currently available therapies, includ...
Saved in:
| Main Authors: | Igor Puzanov, Douglas B. Johnson, Kathryn E. Beckermann, Pradeep C. Jolly, Ju Y. Kim, Jennifer Bordeaux, W. Kimryn Rathmell |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2017-08-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/5/1/1.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma
by: Brian L. Teng, et al.
Published: (2011-10-01) -
VHL type 2B mutations retain VBC complex form and function.
by: Kathryn E Hacker, et al.
Published: (2008-01-01) -
Therapies in Refractory Metastatic Renal Cell Carcinoma
by: Stephanie Berg, et al.
Published: (2022-11-01) -
Medullary Thyroid Carcinoma Presenting as Metastatic Disease to the Breast
by: Archana P. Kanteti, et al.
Published: (2020-01-01) -
Medullary Aplasia Revealing a Metastatic Prostatic Adenocarcinoma
by: Idriss Ziani, et al.
Published: (2021-01-01)